What is Nuvation Bio's license — revenue?

Nuvation Bio (NUVB) reported license — revenue of $64.72M in Q1 2026.

How has Nuvation Bio's license — revenue changed year-over-year?

Nuvation Bio's license — revenue increased by 1998.5% year-over-year, from $3.08M to $64.72M.

What does license — revenue mean?

This metric represents the total revenue recognized from licensing agreements, excluding any assessed taxes. It reflects the financial value generated from granting rights to intellectual property or therapeutic candidates to third-party partners. This is a key indicator of the company's ability to monetize its research and development pipeline through strategic partnerships.

Nuvation Bio NUVB License — Revenue

Other product segments

Product Revenue

$18.5M+2,213%

Royalty Revenue

$1.4M+600%

Research And Development Service Revenue

$700K-63.2%

Similar metrics at other companies

BCRXLicense — Revenue (Gross)

$3.02M—

DNTHLicense — Revenue

$463K-60.2%

ANABLicense — Revenue

$0-100%

CPRXLicense And Other Revenue — Revenue

$47K+124%

INVALicense And Other Revenue — Revenue

$1.46M+167%

TGTXLicense Revenue — Revenue

$3.61M+201%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's license — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's license — revenue?: Nuvation Bio (NUVB) reported license — revenue of $64.72M in Q1 2026.
How has Nuvation Bio's license — revenue changed year-over-year?: Nuvation Bio's license — revenue increased by 1998.5% year-over-year, from $3.08M to $64.72M.
What does license — revenue mean?: This metric represents the total revenue recognized from licensing agreements, excluding any assessed taxes. It reflects the financial value generated from granting rights to intellectual property or therapeutic candidates to third-party partners. This is a key indicator of the company's ability to monetize its research and development pipeline through strategic partnerships.